Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

ItalyBack to Italy

Clinical trials in Crema

7 clinical trials in Crema, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Crema at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Crema

Open in trial search

Hormone receptor positive HER2 negative breast cancer

Recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Pancreatic carcinoma

Recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Fondazione GONO G.I.

Hereditary haemorrhagic telangiectasia

Not yet recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Vaderis Therapeutics AG

Oesophageal adenocarcinoma

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Fondazione GONO G.I.

Non-small cell lung cancer

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universita' Vita-salute S. Raffaele

Colon cancer stage III+1

Not yet recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fondazione GONO G.I.

Metastatic malignant melanoma

Not recruiting
Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Amgen Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Crema

What the registry says about research in the country

01 Crema
Neoplasms Research in Crema
Clinical trial activity in Crema is focused entirely on neoplasms, with all studies currently recruiting. The research landscape brings together breast, colon, melanoma, pancreatic, and lung cancer studies, reflecting a strong interest in improving cancer treatment choices and outcomes. Breast cancer research in premenopausal women with high-risk HR-positive/HER2-negative disease Colon cancer studies for resected stage III and high-risk stage II disease Melanoma trials in unresectable or metastatic disease Pancreatic cancer and non-small cell lung cancer investigations in advanced settings These studies are mainly designed to test better treatment strategies, refine therapy selection, and improve cancer control for patients with difficult-to-treat or high-risk disease.
Breast Cancer
One trial in breast cancer is exploring whether a gene-expression-based approach can help guide adjuvant treatment decisions for premenopausal women with HR-positive/HER2-negative early disease. Early breast cancer Gene expression testing Adjuvant treatment decision-making Survival without invasive recurrence The goal is to see whether more personalized treatment planning can maintain effectiveness while helping avoid unnecessary chemotherapy.
Colorectal Cancer
Research in colorectal cancer is centered on patients with resected stage III or high-risk stage II disease, with studies looking at ways to improve post-surgery treatment and detect who may benefit most from stronger therapy. Stage III colon cancer High-risk stage II colon cancer Circulating tumor DNA Post-operative treatment intensification These trials aim to improve the effectiveness of adjuvant therapy by using tumor biomarkers to guide treatment choices after surgery.
Melanoma
In melanoma, the trial activity focuses on unresectable or metastatic disease, comparing a newer treatment approach with an established immune-based option. Metastatic melanoma Immunotherapy Treatment effectiveness First treatment for advanced disease The purpose is to evaluate whether the investigational therapy can match or improve outcomes in patients starting treatment for advanced melanoma.
Pancreatic Cancer
Trials in advanced pancreatic cancer are studying treatment strategies after initial chemotherapy, with attention to whether a switch in maintenance therapy can better support patient outcomes. Advanced pancreatic cancer Maintenance therapy Overall survival Post-induction treatment planning This research is intended to refine how ongoing therapy is used once early treatment has been completed.
Non-Small Cell Lung Cancer
Non-small cell lung cancer studies in Crema are examining how to reduce very rapid disease worsening and early death in patients with advanced illness, particularly those with strong PD-L1 expression. Advanced NSCLC Cemiplimab-based treatment Hyperprogression Early death risk The research focuses on improving the safety and effectiveness of treatment by identifying better ways to manage immune-based therapy in this setting.
Back to ItalyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.